Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
05/2005
05/12/2005WO2005042521A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
05/12/2005WO2005042520A1 Benzimidazolyl derivatives
05/12/2005WO2005042517A2 Bipiperidinyl derivatives useful as inhibitors of chemokine receptors
05/12/2005WO2005042516A2 Ligands of melanocortin receptors and compositions and methods related thereto
05/12/2005WO2005042515A1 Novel crystalline forms of {2-[1-(3,5-bis-trifluoromethylbenzyl)-5-pyridin-4-yl-1h-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
05/12/2005WO2005042514A2 Naphthalene-1,5-disulfonic acid salts of a substituted 4-amino-1-(pyridylmethyl)piperidine compound
05/12/2005WO2005042502A1 Amide derivatives
05/12/2005WO2005042501A1 Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders
05/12/2005WO2005042500A1 Arylindenopyridines and arylindenopyridines and their use as adenosine a2a receptor antagonist
05/12/2005WO2005042498A2 4-amino (aza) quinoline derivatives as capsaicin receptor agonists
05/12/2005WO2005042497A2 Benzimidazoles useful as modulators of ion channels
05/12/2005WO2005042496A1 (benzimidazol-2-yl)-phenyl-benzyl-amine derivatives and methods for inhibiting heparanase activity
05/12/2005WO2005042489A1 N-substituted benzene sulfonamides
05/12/2005WO2005042488A1 Pyridine compounds as inhibitors of dipeptidyl peptidase iv
05/12/2005WO2005042464A1 Androgen receptor modulators
05/12/2005WO2005042444A2 Platinum complex and luminescent element
05/12/2005WO2005041971A1 Triazolo-pyridazine compounds and derivatives thereof useful in the treatment of neuropathic pain
05/12/2005WO2005041875A2 Dopamine-, norepinephrine- and serotonin- transporter- selective heterocyclic compounds and their therapeutic applications
05/12/2005WO2005030131A3 Bis-quinazoline compounds for the treatment of bacterial infections
05/12/2005WO2005018531A3 Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof
05/12/2005WO2005014539A3 Pyrrole-based hmg-coa reductase inhibitors
05/12/2005WO2005003100A3 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis
05/12/2005WO2005003099A3 Pyrimidines useful as modulators of voltage-gated ion channels
05/12/2005WO2004105757A3 Use of rho-kinase inhibitors in the treatment of aneurysm and cardiac hypertrophy
05/12/2005WO2004092145A8 Alpha substituted carboxylic acid as ppar modulators
05/12/2005WO2004026836A8 1-pyridin-4-yl-urea derivatives
05/12/2005WO2003006454A8 Heterocyclic carboxamides and their use as fungicides
05/12/2005US20050101788 Method for manufacture of sertindole
05/12/2005US20050101785 Reaction of cyano compound with silylalkylisocyanide for active imidazoles
05/12/2005US20050101657 Pyrrole derivatives for preventing or treating cancer sensitive to hormones; administered with luteininzing hormone releasing hormone derivative
05/12/2005US20050101654 Process for the preparation of N-amino substituted heterocyclic compounds
05/12/2005US20050101651 Viricides; protease inbhibitors; useful for inhibiting the activity of picornaviral 3C proteases; for example, 6-carbamoyl-4S-{2S-[(5-naphthalen-1-yl-1H-pyrrole-2-carbonyl)-amino-3-phenyl-propionylamino}-hex-2(trans)-enoic acid ethyl ester
05/12/2005US20050101644 Benzylether amine compounds useful as CCR-5 antagonists
05/12/2005US20050101641 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
05/12/2005US20050101634 Bis(5-aeyl-2-pyridyl) derivatives
05/12/2005US20050101630 4-Anilino-, phenoxy-, or phenylthio-substituted; inhibitors of specific kinase enzymes, such as MEK enzymes
05/12/2005US20050101617 Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors
05/12/2005US20050101616 Quinazoline analogs as receptor tyrosine kinase inhibitors
05/12/2005US20050101614 Heterocyclic GABAA subtype selective receptor modulators
05/12/2005US20050101609 Quinazoline derivatives as kinase inhibitors
05/12/2005US20050101600 4-Hydroxy-1-toluenesulfonyl-2,3,4,5-tetrahydro-1H-1-benzazepine, for example; useful as the preventive and/or treatment medicine against diseases caused by stress
05/12/2005US20050101590 Cannabinoid receptor agonists
05/12/2005US20050101589 Antimicrobial quinolones, their compositions and uses
05/12/2005US20050101588 7-Amino alkylidenyl-heterocyclic quinolones and naphthyridones
05/12/2005US20050101586 Novel 5-HT2A receptor ligands
05/12/2005US20050101569 Methods and compositions for selectin inhibition
05/12/2005US20050101567 Using a sulfonamide containing compound
05/12/2005US20050101521 Bind as ligands to human peroxisome proliferator activated receptor to activate receptor and thereby exhibit potent effects of decreasing neutral fat, cholesterol, and blood sugar; for example, 2-[[4-ethoxy-3-[[[4-(2-pyridyloxy)phenyl]carbonylamino]methyl]phenyl]methyl]butyric acid; diabetes treatment
05/12/2005CA2544377A1 Bipiperidinyl derivatives useful as inhibitors of chemokine receptors
05/12/2005CA2544350A1 N-substituted benzene sulfonamides
05/12/2005CA2543918A1 Benzimidazoles useful as modulators of ion channels
05/12/2005CA2543715A1 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
05/12/2005CA2543710A1 Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders
05/12/2005CA2543533A1 2-cyanopyrrolidinecarboxamide compound
05/12/2005CA2543529A1 Pyridine compounds as inhibitors of dipeptidyl peptidase iv
05/12/2005CA2543346A1 Benzimidazolyl derivatives
05/12/2005CA2543345A1 Androgen receptor modulators
05/12/2005CA2543248A1 Process for making sterile aripiprazole of desired mean particle size
05/12/2005CA2543089A1 Dopamine-, norepinephrine- and serotonin- transporter- selective heterocyclic compounds and their therapeutic applications
05/12/2005CA2543012A1 Naphthalene-1,5-disulfonic acid salts of a substituted 4-amino-1-(pyridylmethyl)piperidine compound
05/12/2005CA2542536A1 Triazolo-pyridazine compounds and derivatives thereof useful in the treatment of neuropathic pain
05/12/2005CA2540686A1 Arylindenopyridines and arylindenopyridines and their use as adenosine a2a receptor antagonist
05/12/2005CA2540342A1 4-amino (aza) quinoline derivatives as capsaicin receptor agonists
05/11/2005EP1529530A1 Compounds affecting glucokinase
05/11/2005EP1529044A2 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
05/11/2005EP1529043A1 Novel process
05/11/2005EP1529042A1 Arylamides
05/11/2005EP1529041A1 NOVEL PRODRUGS OF 1-METHYL-2(4-AMIDINOPHENYLAMINOMETHYL)-BENZIMIDAZOL-5-YL-CARBOXYLIC ACID-( i N /i -2-PYRIDIL- i N /i -2-HYDROXYCARBONYLETHYL)-AMIDE, PRODUCTION AND USE THEREOF AS MEDICAMENTS
05/11/2005EP1529031A1 Acylated arylcycloalkylamines and their use as pharmaceuticals
05/11/2005EP1528924A1 Mch1r antagonists
05/11/2005EP1363899B1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists
05/11/2005EP1254138B1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
05/11/2005EP1068224B1 Pharmaceuticals for the imaging of angiogenic disorders
05/11/2005CN1615300A Benzimidazole derivatives and their use as GNRH antagonists
05/11/2005CN1615299A Xanthine oxidase inhibitors
05/11/2005CN1615169A Purification of impure materials using non-aqueous solvents
05/11/2005CN1615133A Crystalline solids of carvedilol and processes for their preparation
05/11/2005CN1613852A Cesium triazoleamide compounds and their preparation and use
05/11/2005CN1201150C Composite, chemical luminescent system and its applications
05/11/2005CN1200938C Process for preparing 8-methoxy-quinolone
05/10/2005US6891044 Indazole compounds and pharmaceutical compositions for Inhibiting protein kinases, and methods for their use
05/10/2005US6891041 Reacting phthalidyl-3-triphenylphosphonium salt with 4-pyridine aldehyde in the presence of a basic adjuvant, then reacting with hydrazine hydrate and acid treatment; avoids environmental and safety problems
05/10/2005US6891008 2,2,6,6 diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides
05/10/2005US6890940 Immoglobulin E (IgE) antibody production inhibitor; treating allergic immune diseases such as asthma, dermatitis, inflammatory bowel disease and allergic opthalmopathy
05/10/2005US6890938 Antiinflammatory agents
05/10/2005US6890937 Inhibiting the activity of one or more of MMP-2, MMP-9 and MMP-13, while exhibiting substantially less inhibitory activity against MMP-1
05/10/2005US6890935 Pharmaceutical compositions and methods for use
05/10/2005US6890931 Methods of treating disorders with group I mGluR antagonists
05/10/2005US6890928 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
05/10/2005US6890926 Antitumor agents
05/10/2005US6890925 Treating insulin resistance, hypertension, angina, ischemia, renal disease or Raynaud's disease, by administering pyrazole derivatives such as 1-(p-(morpholinocarbonylamino)phenyl)-3,5-di(trifluoromethyl)pyrazole
05/10/2005US6890924 Substituted bicyclic derivatives for the treatment of abnormal cell growth
05/10/2005US6890916 Indole derivatives useful for the treatment of CNS disorders
05/10/2005US6890915 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)
05/10/2005US6890885 Herbicidal composition
05/10/2005CA2250569C Novel phenanthridines substituted in the 6 position
05/06/2005WO2005040355A2 Tao kinase modulators and methods of use
05/06/2005WO2005040338A2 Constrained alkaloid immunogens and antibodies and uses thereof
05/06/2005WO2005040163A1 Heterocyclic compounds that block the effects of advanced glycation end products (age)
05/06/2005WO2005040155A1 Pyrimidin-2-amine derivates and their use as a2b adenosine receptor antagonists
1 ... 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 ... 1080